Cardiac AI Monitoring and Diagnostics Market Analysis

Cardiac AI Monitoring and Diagnostics Market Analysis

To get key market trends

  Download Free Sample

Based on product, the market is divided into hardware, software solutions, and services. The hardware segment is estimated to account for USD 5 billion by 2032.

• Hardware advancements particularly in graphics processing units (GPUs) and tensor processing units (TPUs) are pivotal in boosting cardiac AI monitoring and diagnostics by facilitating the execution of computation-intensive algorithms. With significantly enhanced computational power these advanced processors enable real-time analysis of cardiac data, expediting diagnostic insights and decision-making processes.

   

• Miniaturized and energy-efficient hardware solutions such as system-on-chip (SoC) platforms and field-programmable gate arrays (FPGAs) enable AI algorithms to be deployed directly on wearable devices or medical sensors. This facilitates real-time cardiac monitoring at the point of care or even in remote settings without the need for continuous internet connectivity improving accessibility and patient convenience.

   

• Additionally, solid-state storage technologies such as solid-state drives (SSDs) and non-volatile memory express (NVMe) offer high-speed data access facilitating efficient storage and retrieval of large volumes of cardiac data. This includes patient records, medical images, and continuous monitoring data, supporting comprehensive AI-driven analytics and retrospective analysis in cardiovascular healthcare. Thus, stimulating the growth of the segment.

Based on type, the cardiac AI monitoring and diagnostics market is bifurcated into cardiac diagnostics and cardiac monitoring. Further, the cardiac diagnostics is segmented into imaging, ECG-based, and other diagnostic techniques. The cardiac diagnostics segment accounted for USD 574.1 million in 2023.

• AI algorithms can detect subtle patterns or abnormalities in cardiac data enabling early identification of cardiovascular diseases before symptoms manifest. This early detection allows for timely intervention and treatment potentially preventing serious complications.

   

• Diagnostic tools streamline the diagnostic process by automating routine tasks such as image analysis and data interpretation. This increases efficiency in healthcare delivery, allowing clinicians to focus their time and expertise on more complex cases and patient care.

   

• Further, AI-based monitoring systems can continuously track cardiac parameters such as heart rate, rhythm, and blood pressure in real-time. This continuous monitoring provides clinicians with comprehensive insights into patient’s cardiac health status, facilitating proactive management, and early intervention to detect abnormalities. Thus, such aforementioned factors are expected to augment the segmental growth.

   

Based on application, the cardiac AI monitoring and diagnostics market is segmented into cardiac arrhythmias, stroke, ischemic heart disease, stenosis, and other applications. The cardiac arrhythmias segment is estimated to account for USD 2.7 billion revenue by 2032.

• AI algorithms can analyze continuous electrocardiogram (ECG) recordings to detect subtle changes in heart rhythm indicative of arrhythmias. By continuously monitoring patients, AI systems can identify arrhythmic events early allowing for timely intervention and treatment.

   

• AI-based arrhythmia detection algorithms can achieve high levels of accuracy in distinguishing between different types of arrhythmias including atrial fibrillation, ventricular tachycardia, and bradycardia. This improved accuracy reduces the likelihood of false positives or false negatives in diagnosis, leading to more effective patient management.

   

• Further, continuous monitoring of heart rhythm via AI-powered wearable devices featuring integrated ECG sensors enables timely detection of arrhythmic episodes even in non-clinical settings. This ongoing monitoring provides valuable insights into arrhythmia patterns and triggers, fostering a better understanding of these conditions.

   

• Thus, the aforementioned factors are anticipated to boost segmental growth.

   

Based on end-use, the market is classified into hospitals, specialty clinics, diagnostic centres, research and academic institutes, and other end-users. The hospital segment accounted for USD 348 million in 2023.

• Hospitals utilize AI-powered ECG analysis software to detect and classify various types of arrhythmias including atrial fibrillation, ventricular tachycardia, and bradycardia. This enables prompt diagnosis and appropriate management of arrhythmic disorders reducing the risk of complications such as stroke or sudden cardiac arrest.

   

• AI algorithms aid clinicians in interpreting cardiac imaging tests such as echocardiograms, cardiac MRI scans, and CT angiograms. These algorithms can detect subtle abnormalities, measure cardiac function, and assist in diagnosing conditions such as coronary artery disease, cardiomyopathies, and valvular disorders.

   

• Moreover, hospitals deploy AI-enabled remote monitoring systems that allow continuous tracking of patient’s cardiac health outside clinical settings. Wearable cardiac devices equipped with AI algorithms transmit real-time data including heart rate, rhythm, and blood pressure to healthcare providers, enabling early detection of cardiac abnormalities and timely intervention. Thus, all these aforementioned factors are expected to drive segmental growth.

North America cardiac AI monitoring and diagnostics market accounted for USD 399.2 million revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.

• North America leads the global charge in healthcare technology innovation with a multitude of companies and research institutions spearheading the development of AI algorithms and solutions customized for cardiac monitoring and diagnostics.

   

• The prevalence of cardiovascular diseases (CVDs) is notably elevated in North America, attributed to factors such as high rates of obesity, sedentary lifestyles, and an aging population. For instance, the Centers for Disease Control and Prevention (CDCP) reports that heart disease claims one life every 33 seconds in the U.S., with nearly 695,000 deaths attributed to heart disease in 2021, accounting for one out of every five deaths.

   

• The region boasts world-renowned medical institutions, healthcare professionals, and clinical experts with specialized knowledge in cardiovascular medicine. Their expertise in cardiology coupled with the integration of AI technologies, enables the delivery of high-quality cardiac care, accurate diagnostics, and personalized treatment strategies. Thus, these factors are expected to propel market growth in North America.